CF
ABMD

Centaurus Financial’s Abiomed Inc ABMD Stock Holding History

Centaurus Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-800
Closed -$197K – 924
2022
Q3 		$197K Hold
800
– – 0.02% 628
2022
Q2 		$198K Sell
800
-300
-27% -$81K 0.02% 619
2022
Q1 		$364K Hold
1,100
– – 0.03% 496
2021
Q4 		$395K Hold
1,100
– – 0.03% 500
2021
Q3 		$358K Buy
1,100
+200
+22% +$67.8K 0.03% 505
2021
Q2 		$281K Hold
900
– – 0.02% 585
2021
Q1 		$287K Buy
900
+16
+2% +$5.12K 0.03% 510
2020
Q4 		$287K Buy
884
+30
+4% +$8.3K 0.03% 478
2020
Q3 		$237K Buy
854
+354
+71% +$102K 0.03% 421
2020
Q2 		$121K Buy
+500
New +$100K 0.02% 545
2018
Q3 		– Sell
-502
Closed -$205K – 2204
2018
Q2 		$205K Buy
+502
New +$182K 0.03% 508

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Centaurus Financial's ABMD Position: Q4 2022 in Review

Centaurus Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 800 shares — an estimated $197K sold.

Centaurus Financial first reported a position in ABMD in Q2 2018 and held it in 11 quarters. The position peaked at $395K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Centaurus Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Centaurus Financial sold 800 Abiomed Inc shares in Q4 2022, an estimated $197K.
  • Centaurus Financial first reported a position in Abiomed Inc in Q2 2018 and held it in 11 quarters.
  • Centaurus Financial's Abiomed Inc position peaked at $395K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Centaurus Financial's 13F filing for Q4 2022, filed 13 Feb 2023.